| Application no. and date | 16738609.3 (espacenet) (Federated) (European Patent Register), 20160628 | | Patent/reg. no. and date | DK/EP 3313528, 20210804 | | Publication date | 20180502 | | Priority no. and date | US 201562185968 P, 20150629, US 201562239965 P, 20151011, US 201562262574 P, 20151203 | | EP pub. no. and date |
EP 3313528 20180502 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V159281DK | | Inventor | ROBBINS, Michael Darron, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543, US,
MULLIGAN, Christopher Lee, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, New Jersey 08543, US,
BARTLETT, Justin Blake, 9 Coddington CT.
Basking Ridge, New Jersey 07920, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/573 (2006.01) , A61K 39/395 (2006.01) , A61P 35/02 (2006.01) | | Title | IMMUNTERAPEUTISKE DOSERINGSSKEMAER OMFATTENDE POMALIDOMID OG ET ANTI-CS1-ANTISTOF TIL BEHANDLING AF CANCER | | Int. application no. | US2016039723 | | Int. publication no. | WO2017003990 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
